JPWO2023121971A5 - - Google Patents

Info

Publication number
JPWO2023121971A5
JPWO2023121971A5 JP2024534724A JP2024534724A JPWO2023121971A5 JP WO2023121971 A5 JPWO2023121971 A5 JP WO2023121971A5 JP 2024534724 A JP2024534724 A JP 2024534724A JP 2024534724 A JP2024534724 A JP 2024534724A JP WO2023121971 A5 JPWO2023121971 A5 JP WO2023121971A5
Authority
JP
Japan
Prior art keywords
cell
optionally substituted
compound
unsaturated
branched
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024534724A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025500824A5 (https=
JP2025500824A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/053193 external-priority patent/WO2023121971A1/en
Publication of JP2025500824A publication Critical patent/JP2025500824A/ja
Publication of JP2025500824A5 publication Critical patent/JP2025500824A5/ja
Publication of JPWO2023121971A5 publication Critical patent/JPWO2023121971A5/ja
Pending legal-status Critical Current

Links

JP2024534724A 2021-12-20 2022-12-16 四価脂質化合物を含むナノ材料 Pending JP2025500824A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163291593P 2021-12-20 2021-12-20
US63/291,593 2021-12-20
US202263354640P 2022-06-22 2022-06-22
US63/354,640 2022-06-22
PCT/US2022/053193 WO2023121971A1 (en) 2021-12-20 2022-12-16 Nanomaterials comprising tetravalent lipid compounds

Publications (3)

Publication Number Publication Date
JP2025500824A JP2025500824A (ja) 2025-01-15
JP2025500824A5 JP2025500824A5 (https=) 2025-12-19
JPWO2023121971A5 true JPWO2023121971A5 (https=) 2025-12-19

Family

ID=85157420

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024534724A Pending JP2025500824A (ja) 2021-12-20 2022-12-16 四価脂質化合物を含むナノ材料

Country Status (6)

Country Link
US (1) US20240358841A1 (https=)
EP (1) EP4452926A1 (https=)
JP (1) JP2025500824A (https=)
AU (1) AU2022421708A1 (https=)
CA (1) CA3241503A1 (https=)
WO (1) WO2023121971A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12569438B2 (en) 2019-07-29 2026-03-10 Georgia Tech Research Corporation Nanomaterials containing constrained lipids and uses thereof
US12435035B2 (en) 2020-01-09 2025-10-07 Guide Therapeutics, Llc Nanomaterials
IL303845A (en) 2021-01-20 2023-08-01 Beam Therapeutics Inc Nanomaterials include a degradable property
KR20230131863A (ko) 2021-01-20 2023-09-14 빔 테라퓨틱스, 인크. 나노물질
CN121241046A (zh) * 2023-05-30 2025-12-30 解放生物股份有限公司 脂质化合物、组合物及其用途
WO2025059599A1 (en) * 2023-09-13 2025-03-20 Tessera Therapeutics, Inc. Lipid nanoparticles for delivery of therapeutic payloads to cells
WO2025193861A2 (en) * 2024-03-12 2025-09-18 Tessera Therapeutics, Inc. Lipid nanoparticles for delivery of therapeutic payloads to cells
WO2026003582A2 (en) 2024-06-27 2026-01-02 Axelyf ehf. Lipids and lipid nanoparticles

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030083272A1 (en) 1997-09-19 2003-05-01 Lahive & Cockfield, Llp Sense mrna therapy
US6670499B1 (en) * 1999-11-08 2003-12-30 Daicel Chemical Industries, Ltd. Adamantane derivatives and processes for the preparation thereof
WO2003101952A2 (en) * 2002-05-31 2003-12-11 The Regents Of The University Of California Polyamine-mediated transfection
JP2005181734A (ja) * 2003-12-19 2005-07-07 Fuji Photo Film Co Ltd 画像記録材料
AU2009238175C1 (en) 2008-04-15 2023-11-30 Arbutus Biopharma Corporation Novel lipid formulations for nucleic acid delivery
US20150165054A1 (en) 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting caspase-9 point mutations
ES2895651T3 (es) * 2013-12-19 2022-02-22 Novartis Ag Lípidos y composiciones lipídicas para la administración de agentes activos
EP4286012A3 (en) 2015-09-17 2024-05-29 ModernaTX, Inc. Compounds and compositions for intracellular delivery of therapeutic agents
JP7109784B2 (ja) 2015-10-23 2022-08-01 プレジデント アンド フェローズ オブ ハーバード カレッジ 遺伝子編集のための進化したＣａｓ９蛋白質
KR102547316B1 (ko) 2016-08-03 2023-06-23 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 아데노신 핵염기 편집제 및 그의 용도
JP7436990B2 (ja) * 2018-08-10 2024-02-22 国立大学法人京都大学 カチオン性脂質を用いた心筋細胞へのトランスフェクション方法
WO2020152037A1 (en) * 2019-01-24 2020-07-30 Agfa Nv Radiation curable inkjet inks for interior decoration
KR20210139265A (ko) 2019-02-13 2021-11-22 빔 테라퓨틱스, 인크. 표적 서열에서 핵염기를 변형하기 위한 아데노신 데아미나제 염기 편집기 및 이의 사용 방법

Similar Documents

Publication Publication Date Title
KR101717098B1 (ko) 디글리시드 에테르 유도체 치료법 및 이의 사용 방법
CA3113436A1 (en) Compounds and compositions for intracellular delivery of therapeutic agents
JPWO2022140252A5 (https=)
CN112533893A (zh) 阳离子性脂质
CN104603102A (zh) 阳离子性脂质
EA034650B1 (ru) Ациламинопиримидиновые производные для лечения вирусных инфекций и других заболеваний
CN116456967A (zh) 可离子化脂质体、其制备及在基因递送中的应用
CN116507606B (zh) 基于tes的阳离子脂质
WO2024198497A9 (zh) 氨基脂质、脂质纳米颗粒及其应用
JP2025501967A (ja) 送達のための脂質及び組成物
JPWO2023121971A5 (https=)
JPWO2022159472A5 (https=)
JPWO2022159475A5 (https=)
JPWO2023121975A5 (https=)
JPWO2022159421A5 (https=)
CN120225500A (zh) 用于活性物质递送的脂质化合物及组合物
TW593330B (en) Orally active A1 adenosine receptor agonists
JPWO2022159463A5 (https=)
CN120682115A (zh) 一种氨基酸骨架可电离脂质及其制备方法与应用
US12312292B2 (en) Long chain alkyl esteramine lipid compound, preparation method therefor and application thereof in nucleic acid delivery
JPWO2022140238A5 (https=)
WO2002020510A1 (fr) Composes acidosensibles, leur preparation et utilisations
EP4362920A1 (en) Compositions for delivery of mrna
Zhang et al. Nanotherapeutic Approaches of Interleukin-3 to Clear the 𝜶-Synuclein Pathology in Mouse Models of Parkinson’s
TW202532053A (zh) 用於遞送治療劑的組成物和化合物